TERM ID="NYU_TERM_1" STRING="Clinical Excellence" FREQUENCY=1 START=445 END=464 LEMMA="CLINICAL EXCELLENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="Coagulation" FREQUENCY=1 START=668 END=679 LEMMA="COAGULATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="DVT" FREQUENCY=1 START=1322 END=1325 LEMMA="DEEP VEIN THROMBOSIS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_4" STRING="Dabigatran" FREQUENCY=1 START=2549 END=2559 LEMMA="DABIGATRAN" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_5" STRING="Dabigatran dominated rivaroxaban" FREQUENCY=1 START=2549 END=2581 LEMMA="DOMINATED RIVAROXABAN DABIGATRAN" LEMMA_FREQUENCY=1 HEAD_TERM="dominated rivaroxaban" HEAD_LEMMA="DOMINATED RIVAROXABAN"
TERM ID="NYU_TERM_6" STRING="Orthopedic surgery" FREQUENCY=1 START=683 END=701 LEMMA="ORTHOPEDIC SURGERY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="PE" FREQUENCY=1 START=1358 END=1360 LEMMA="PULMONARY EMBOLISM" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_8" STRING="QALY" FREQUENCY=3 START=2290 END=2294 LEMMA="QUALITY ADJUSTED LIFE YEAR" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_9" STRING="QALY" FREQUENCY=3 START=2718 END=2722 LEMMA="QUALITY ADJUSTED LIFE YEAR" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_10" STRING="QALY" FREQUENCY=3 START=2843 END=2847 LEMMA="QUALITY ADJUSTED LIFE YEAR" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_11" STRING="QALYs" FREQUENCY=1 START=1941 END=1946 LEMMA="QUALITY ADJUSTED LIFE YEARS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="RCTs" FREQUENCY=1 START=601 END=605 LEMMA="RANDOMISED CONTROLLED TRIALS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="RE-MODEL" FREQUENCY=3 START=901 END=909 LEMMA="RE-MODEL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_14" STRING="RE-MODEL" FREQUENCY=3 START=2606 END=2614 LEMMA="RE-MODEL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_15" STRING="RE-MODEL" FREQUENCY=3 START=2915 END=2923 LEMMA="RE-MODEL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_16" STRING="RE-NOVATE" FREQUENCY=2 START=813 END=822 LEMMA="RE-NOVATE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_17" STRING="RE-NOVATE" FREQUENCY=2 START=2451 END=2460 LEMMA="RE-NOVATE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_18" STRING="RECORD trials" FREQUENCY=1 START=1112 END=1125 LEMMA="RECORD TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="Rivaroxaban" FREQUENCY=4 START=0 END=11 LEMMA="RIVAROXABAN" LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_20" STRING="Rivaroxaban" FREQUENCY=4 START=1455 END=1466 LEMMA="RIVAROXABAN" LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_21" STRING="Rivaroxaban" FREQUENCY=4 START=1547 END=1558 LEMMA="RIVAROXABAN" LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_22" STRING="Rivaroxaban" FREQUENCY=4 START=2347 END=2358 LEMMA="RIVAROXABAN" LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_23" STRING="STA" FREQUENCY=1 START=516 END=519 LEMMA="SINGLE TECHNOLOGY APPRAISAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_24" STRING="STA states" FREQUENCY=1 START=3512 END=3522 LEMMA="STA STATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="THR" FREQUENCY=3 START=1220 END=1223 LEMMA="TOTAL HIP REPLACEMENT" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_26" STRING="THR" FREQUENCY=3 START=1432 END=1435 LEMMA="TOTAL HIP REPLACEMENT" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_27" STRING="THR" FREQUENCY=3 START=1788 END=1791 LEMMA="TOTAL HIP REPLACEMENT" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_28" STRING="TKR" FREQUENCY=3 START=1253 END=1256 LEMMA="TOTAL KNEE REPLACEMENT" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_29" STRING="TKR" FREQUENCY=3 START=1450 END=1453 LEMMA="TOTAL KNEE REPLACEMENT" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_30" STRING="TKR" FREQUENCY=3 START=1795 END=1798 LEMMA="TOTAL KNEE REPLACEMENT" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_31" STRING="VTE" FREQUENCY=2 START=276 END=279 LEMMA="VENOUS THROMBOEMBOLISM" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_32" STRING="VTE" FREQUENCY=2 START=1542 END=1545 LEMMA="VENOUS THROMBOEMBOLISM" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_33" STRING="base-case analyses" FREQUENCY=1 START=1807 END=1825 LEMMA="BASE-CASE ANALYSIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_34" STRING="clinical effectiveness" FREQUENCY=1 START=169 END=191 LEMMA="CLINICAL EFFECTIVENESS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_35" STRING="comparing RECORD" FREQUENCY=2 START=2582 END=2598 LEMMA="COMPARING RECORD" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_36" STRING="comparing RECORD" FREQUENCY=2 START=2677 END=2693 LEMMA="COMPARING RECORD" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_37" STRING="comparing rivaroxaban" FREQUENCY=1 START=607 END=628 LEMMA="COMPARING RIVAROXABAN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_38" STRING="controlled trials" FREQUENCY=1 START=582 END=599 LEMMA="CONTROLLED TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_39" STRING="cost-effectiveness" FREQUENCY=2 START=196 END=214 LEMMA="COST-EFFECTIVENESS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_40" STRING="cost-effectiveness" FREQUENCY=2 START=3129 END=3147 LEMMA="COST-EFFECTIVENESS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_41" STRING="cost-effectiveness of rivaroxaban" FREQUENCY=1 START=196 END=229 LEMMA="RIVAROXABAN COST-EFFECTIVENESS" LEMMA_FREQUENCY=1 HEAD_TERM="cost-effectiveness" HEAD_LEMMA="COST-EFFECTIVENESS"
TERM ID="NYU_TERM_42" STRING="dabigatran" FREQUENCY=4 START=785 END=795 LEMMA="DABIGATRAN" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_43" STRING="dabigatran" FREQUENCY=4 START=1868 END=1878 LEMMA="DABIGATRAN" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_44" STRING="dabigatran" FREQUENCY=4 START=2759 END=2769 LEMMA="DABIGATRAN" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_45" STRING="dabigatran" FREQUENCY=4 START=3192 END=3202 LEMMA="DABIGATRAN" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_46" STRING="dabigatran RCTs" FREQUENCY=1 START=2532 END=2547 LEMMA="DABIGATRAN RCT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_47" STRING="deep vein thrombosis" FREQUENCY=1 START=1300 END=1320 LEMMA="DEEP VEIN THROMBOSIS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_48" STRING="distributions" FREQUENCY=1 START=2064 END=2077 LEMMA="DISTRIBUTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_49" STRING="dominated rivaroxaban" FREQUENCY=1 START=2560 END=2581 LEMMA="DOMINATED RIVAROXABAN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_50" STRING="economic model" FREQUENCY=1 START=1704 END=1718 LEMMA="ECONOMIC MODEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_51" STRING="elective THR" FREQUENCY=1 START=3668 END=3680 LEMMA="ELECTIVE THR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_52" STRING="elective TKB" FREQUENCY=1 START=3684 END=3696 LEMMA="ELECTIVE TKB" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_53" STRING="elective hip" FREQUENCY=1 START=310 END=322 LEMMA="ELECTIVE HIP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_54" STRING="enoxaparin" FREQUENCY=6 START=634 END=644 LEMMA="ENOXAPARIN" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_55" STRING="enoxaparin" FREQUENCY=6 START=801 END=811 LEMMA="ENOXAPARIN" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_56" STRING="enoxaparin" FREQUENCY=6 START=1180 END=1190 LEMMA="ENOXAPARIN" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_57" STRING="enoxaparin" FREQUENCY=6 START=1499 END=1509 LEMMA="ENOXAPARIN" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_58" STRING="enoxaparin" FREQUENCY=6 START=1853 END=1863 LEMMA="ENOXAPARIN" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_59" STRING="enoxaparin" FREQUENCY=6 START=3177 END=3187 LEMMA="ENOXAPARIN" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_60" STRING="enoxaparin for the secondary outcome" FREQUENCY=1 START=1499 END=1535 LEMMA="SECONDARY OUTCOME ENOXAPARIN" LEMMA_FREQUENCY=1 HEAD_TERM="enoxaparin" HEAD_LEMMA="ENOXAPARIN"
TERM ID="NYU_TERM_61" STRING="evidence review group" FREQUENCY=1 START=125 END=146 LEMMA="EVIDENCE REVIEW GROUP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_62" STRING="fatal PEs" FREQUENCY=1 START=3352 END=3361 LEMMA="FATAL PE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_63" STRING="incremental cost" FREQUENCY=3 START=2269 END=2285 LEMMA="INCREMENTAL COST" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_64" STRING="incremental cost" FREQUENCY=3 START=2697 END=2713 LEMMA="INCREMENTAL COST" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_65" STRING="incremental cost" FREQUENCY=3 START=2822 END=2838 LEMMA="INCREMENTAL COST" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_66" STRING="incremental costs" FREQUENCY=1 START=1884 END=1901 LEMMA="INCREMENTAL COST" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_67" STRING="interventions" FREQUENCY=1 START=3453 END=3466 LEMMA="INTERVENTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_68" STRING="life-years" FREQUENCY=1 START=1929 END=1939 LEMMA="LIFE-YEAR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_69" STRING="manufacturer" FREQUENCY=2 START=377 END=390 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_70" STRING="manufacturer" FREQUENCY=2 START=1688 END=1701 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_71" STRING="marketing authorisation" FREQUENCY=1 START=3553 END=3576 LEMMA="MARKETING AUTHORISATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_72" STRING="non-fatal pulmonary embolism" FREQUENCY=1 START=1328 END=1356 LEMMA="NON-FATAL PULMONARY EMBOLISM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_73" STRING="primary outcome" FREQUENCY=1 START=1277 END=1292 LEMMA="PRIMARY OUTCOME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_74" STRING="pulmonary embolism" FREQUENCY=2 START=1338 END=1356 LEMMA="PULMONARY EMBOLISM" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_75" STRING="pulmonary embolism" FREQUENCY=2 START=740 END=758 LEMMA="PULMONARY EMBOLISM" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_76" STRING="quality-adjusted life-years" FREQUENCY=1 START=1912 END=1939 LEMMA="QUALITY-ADJUSTED LIFE-YEAR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_77" STRING="randomised controlled trials" FREQUENCY=1 START=571 END=599 LEMMA="RANDOMISED CONTROLLED TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_78" STRING="receiving prophylaxis" FREQUENCY=1 START=1762 END=1783 LEMMA="RECEIVING PROPHYLAXIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_79" STRING="receiving prophylaxis for THR" FREQUENCY=1 START=1762 END=1791 LEMMA="TOTAL HIP REPLACEMENT RECEIVING PROPHYLAXIS" LEMMA_FREQUENCY=1 HEAD_TERM="receiving prophylaxis" HEAD_LEMMA="RECEIVING PROPHYLAXIS"
TERM ID="NYU_TERM_80" STRING="relative risk reductions" FREQUENCY=1 START=1392 END=1416 LEMMA="RELATIVE RISK REDUCTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_81" STRING="rivaroxaban" FREQUENCY=6 START=218 END=229 LEMMA="RIVAROXABAN" LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_82" STRING="rivaroxaban" FREQUENCY=6 START=1141 END=1152 LEMMA="RIVAROXABAN" LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_83" STRING="rivaroxaban" FREQUENCY=6 START=2246 END=2257 LEMMA="RIVAROXABAN" LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_84" STRING="rivaroxaban" FREQUENCY=6 START=2665 END=2676 LEMMA="RIVAROXABAN" LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_85" STRING="rivaroxaban" FREQUENCY=6 START=2883 END=2894 LEMMA="RIVAROXABAN" LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_86" STRING="rivaroxaban" FREQUENCY=6 START=2984 END=2995 LEMMA="RIVAROXABAN" LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_87" STRING="rivaroxaban RCTs pooled" FREQUENCY=1 START=2479 END=2502 LEMMA="RIVAROXABAN RCTS POOLED" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_88" STRING="rivaroxaban comparing RECORD" FREQUENCY=1 START=2665 END=2693 LEMMA="COMPARING RECORD RIVAROXABAN" LEMMA_FREQUENCY=1 HEAD_TERM="comparing RECORD" HEAD_LEMMA="COMPARING RECORD"
TERM ID="NYU_TERM_89" STRING="riveroxaban" FREQUENCY=1 START=3529 END=3540 LEMMA="RIVEROXABAN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_90" STRING="sampled rivaroxaban" FREQUENCY=1 START=2127 END=2146 LEMMA="SAMPLED RIVAROXABAN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_91" STRING="secondary outcome" FREQUENCY=1 START=1518 END=1535 LEMMA="SECONDARY OUTCOME" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_92" STRING="secondary outcomes" FREQUENCY=1 START=3054 END=3072 LEMMA="SECONDARY OUTCOME" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_93" STRING="single technology appraisal" FREQUENCY=1 START=487 END=514 LEMMA="SINGLE TECHNOLOGY APPRAISAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_94" STRING="technology appraisal" FREQUENCY=2 START=67 END=87 LEMMA="TECHNOLOGY APPRAISAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_95" STRING="technology appraisal" FREQUENCY=2 START=494 END=514 LEMMA="TECHNOLOGY APPRAISAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_96" STRING="total hip replacement" FREQUENCY=2 START=1197 END=1218 LEMMA="TOTAL HIP REPLACEMENT" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_97" STRING="total hip replacement" FREQUENCY=2 START=1197 END=1218 LEMMA="TOTAL HIP REPLACEMENT" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_98" STRING="total hip replacement trial" FREQUENCY=1 START=871 END=898 LEMMA="TOTAL HIP REPLACEMENT TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_99" STRING="total knee arthroplasty trial" FREQUENCY=1 START=1052 END=1081 LEMMA="TOTAL KNEE ARTHROPLASTY TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_100" STRING="total knee replacement" FREQUENCY=2 START=1229 END=1251 LEMMA="TOTAL KNEE REPLACEMENT" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_101" STRING="total knee replacement" FREQUENCY=2 START=1229 END=1251 LEMMA="TOTAL KNEE REPLACEMENT" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_102" STRING="total knee replacement trial" FREQUENCY=1 START=958 END=986 LEMMA="TOTAL KNEE REPLACEMENT TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_103" STRING="vein thrombosis" FREQUENCY=1 START=1305 END=1320 LEMMA="VEIN THROMBOSIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_104" STRING="venous thromboembolism" FREQUENCY=7 START=252 END=274 LEMMA="VENOUS THROMBOEMBOLISM" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_105" STRING="venous thromboembolism" FREQUENCY=7 START=34 END=56 LEMMA="VENOUS THROMBOEMBOLISM" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_106" STRING="venous thromboembolism" FREQUENCY=7 START=252 END=274 LEMMA="VENOUS THROMBOEMBOLISM" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_107" STRING="venous thromboembolism" FREQUENCY=7 START=842 END=864 LEMMA="VENOUS THROMBOEMBOLISM" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_108" STRING="venous thromboembolism" FREQUENCY=7 START=929 END=951 LEMMA="VENOUS THROMBOEMBOLISM" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_109" STRING="venous thromboembolism" FREQUENCY=7 START=1023 END=1045 LEMMA="VENOUS THROMBOEMBOLISM" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_110" STRING="venous thromboembolism" FREQUENCY=7 START=3628 END=3650 LEMMA="VENOUS THROMBOEMBOLISM" LEMMA_FREQUENCY=9
